{"Symbol": "PODD", "AssetType": "Common Stock", "Name": "Insulet Corporation", "Description": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.", "CIK": "1145197", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS", "Address": "9 OAK PARK DRIVE, BEDFORD, MA, US", "OfficialSite": "https://www.insulet.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "17727738000", "EBITDA": "389700000", "PERatio": "42.29", "PEGRatio": "6.05", "BookValue": "17.26", "DividendPerShare": "None", "DividendYield": "None", "EPS": "5.77", "RevenuePerShareTTM": "29.56", "ProfitMargin": "0.202", "OperatingMarginTTM": "0.16", "ReturnOnAssetsTTM": "0.068", "ReturnOnEquityTTM": "0.43", "RevenueTTM": "2071600000", "GrossProfitTTM": "1445700000", "DilutedEPSTTM": "5.77", "QuarterlyEarningsGrowthYOY": "-0.062", "QuarterlyRevenueGrowthYOY": "0.172", "AnalystTargetPrice": "312.27", "AnalystRatingStrongBuy": "6", "AnalystRatingBuy": "14", "AnalystRatingHold": "4", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "42.29", "ForwardPE": "57.14", "PriceToSalesRatioTTM": "8.56", "PriceToBookRatio": "13.83", "EVToRevenue": "8.3", "EVToEBITDA": "40.58", "Beta": "1.303", "52WeekHigh": "289.46", "52WeekLow": "160.19", "50DayMovingAverage": "264.34", "200DayMovingAverage": "243.3", "SharesOutstanding": "70226000", "DividendDate": "None", "ExDividendDate": "None"}